The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.
Abstract
The consensus of evidence from angiographic trials demonstrates both coronary artery and clinical benefits from lowering of lipids by a variety of regimens. The findings of reduced arterial disease progression and increased regression have been convincing but, at best, modest in their magnitude. For example, among those treated intensively in FATS, the mean improvement in proximal stenosis severity per patient was < 1% stenosis, and only 12% of all lesions showed convincing regression. In view of these modest arterial benefits, the associated reductions in cardiovascular events have been surprisingly great. For example, coronary events were reduced 75% in FATS; this was entirely a result of a 93% reduction in the likelihood that a mildly or moderately diseased arterial segment would experience substantial progression to a severe lesion at the time of a clinical event. We believe that the magnitude of the clinical benefit is best explained in terms of this observation, according to the following lines of reasoning. Clinical events most commonly spring from lesions that are initially of mild or moderate severity and then abruptly undergo a disruptive transformation to a severe culprit lesion. The process of plaque fissuring, leading to plaque disruption and thrombosis, triggers most clinical coronary events. Fissuring is predicted by a large accumulation of core lipid in the plaque and by a high density of lipid-laden macrophages in its thinned fibrous cap. Lesions with these characteristics constitute only 10-20% of the overall lesion population but account for 80-90% of the acute clinical events. In the experimental setting, normalization of an atherogenic lipid profile substantially decreases the number of lipid-laden intimal macrophages (foam cells) and depletes cholesterol from the core lipid pool. In the clinical setting, intensive lipid lowering virtually halts the progression of mild and moderate lesions to clinical events. Thus, the reduction in clinical events observed in these trials appears to be best explained by the relation of the lipid and foam cell content of the plaque to its likelihood of fissuring and by the effects of lipid-lowering therapy on these "high-risk" features of plaque morphology. The composite of data presented here supports the hypothesis that lipid-lowering therapy selectively depletes (regresses) that relatively small but dangerous subgroup of fatty lesions containing a large lipid core and dense clusters of intimal macrophages. By doing so, these lesions are effectively stabilized and clinical event rate is accordingly decreased.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
Compensatory Enlargement of Human Atherosclerotic Coronary Arteries
Glagov, S., Weisenberg, E., Zarins, C. K., Stankunavicius, R., & Kolettis, G. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162204 · Cited by 3,623
Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
Ludmer, P. L., Selwyn, A. P., Shook, T. L., Wayne, R. R., Mudge, G. H., Alexander, R. W., & Ganz, P. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610233151702 · Cited by 2,425
Can lifestyle changes reverse coronary heart disease?
Ornish, D., Brown, S. E., Billings, J. H., Scherwitz, L. W., Armstrong, W. T., Ports, T. A., McLanahan, S. M., Kirkeeide, R. L., Gould, K. L., & Brand, R. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91656-u · Cited by 2,338
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Self-citationEndothelium‐derived relaxing and contracting factors
Furchgott, R. F., & Vanhoutte, P. M. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.9.2545495 · Cited by 1,993
Ylä-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L., & Steinberg, D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114271 · Cited by 1,880
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Blankenhorn, D. H. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390230069027 · Cited by 1,655
Stamler, J. S., Simon, D. I., Osborne, J. A., Mullins, M. E., Jaraki, O., Michel, T., Singel, D. J., & Loscalzo, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.444 · Cited by 1,471
Angiographic progression of coronary artery disease and the development of myocardial infarction
Ambrose, J. A., Tannenbaum, M. A., Alexopoulos, D., Hjemdahl-Monsen, C. E., Leavy, J., Weiss, M., Borrico, S., Gorlin, R., & Fuster, V. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90356-7 · Cited by 1,452
Rg, G. (1981) · PubMed Central · Cited by 1,314
RICHARDSON, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90953-7 · Cited by 1,258
Langille, B. L., & O'Donnell, F. (1986) · Science · doi:10.1126/science.3941904 · Cited by 1,113
Carew, T. E., Schwenke, D. C., & Steinberg, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7725 · Cited by 1,035
Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231404 · Cited by 1,001
Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
Manninen, V. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410050061031 · Cited by 957
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.
Berliner, J. A., Territo, M. C., Sevanian, A., Ramin, S., Kim, J. A., Bamshad, B., Esterson, M., & Fogelman, A. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114562 · Cited by 925
Kugiyama, K., Kerns, S. A., Morrisett, J. D., Roberts, R., & Henry, P. D. (1990) · Nature · doi:10.1038/344160a0 · Cited by 858
Watts, G. F., Lewis, B., Lewis, E. S., Coltart, D. J., Smith, L. D. R., Swan, A. V., Brunt, J. N. H., & Mann, J. I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90863-x · Cited by 843
Kane, J. P. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450230043027 · Cited by 829
Malondialdehyde-Altered Protein Occurs in Atheroma of Watanabe Heritable Hyperlipidemic Rabbits
Haberland, M. E., Fong, D., & Cheng, L. (1988) · Science · doi:10.1126/science.2455346 · Cited by 748
Atherosclerotic plaque caps are locally weakened when macrophages density is increased
Lendon, C. L., Davies, M. J., Born, G. V. R., & Richardson, P. D. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90235-u · Cited by 547
Lipoprotein oxidation and lipoprotein-induced cytotoxicity.
Hessler, J. R., Morel, D. W., Lewis, L. J., & Chisolm, G. M. (1983) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.3.3.215 · Cited by 541
Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator.
Cooke, J. P., Rossitch, E., Andon, N. A., Loscalzo, J., & Dzau, V. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115481 · Cited by 533
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up
Cashin-Hemphill, L. (1990) · JAMA · doi:10.1001/jama.264.23.3013 · Cited by 493
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.
Rath, M., Niendorf, A., Reblin, T., Dietel, M., Krebber, H. J., & Beisiegel, U. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.579 · Cited by 446
Plaque fissures in human coronary thrombosis
Constantinides, P. (1966) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(66)80056-x · Cited by 426
Mügge, A., Elwell, J. H., Peterson, T. E., Hofmeyer, T. G., Heistad, D. D., & Harrison, D. G. (1991) · Circulation Research · doi:10.1161/01.res.69.5.1293 · Cited by 399
The Relationship Between Plasma and Tissue Lipids in Human Atherosclerosis
SMITH, E. B. (1974) · Advances in Lipid Research · doi:10.1016/b978-0-12-024912-1.50008-9 · Cited by 355
Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis.
Harrison, D. G., Armstrong, M. L., Freiman, P. C., & Heistad, D. D. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113276 · Cited by 352
(1993) · Circulation · doi:10.1161/01.cir.87.1.38 · Cited by 325
Nabel, E. G., Selwyn, A. P., & Ganz, P. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90584-c · Cited by 296
Lipid in the aortic intima the correlation of morphological and chemical characteristics
Smith, E. B., Evans, P. H., & Downham, M. D. (1967) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(67)80079-6 · Cited by 264
DUFFIELD, R. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92527-8 · Cited by 252
Cushing, G. L., Gaubatz, J. W., Nava, M. L., Burdick, B. J., Bocan, T. M., Guyton, J. R., Weilbaecher, D., DeBakey, M. E., Lawrie, G. M., & Morrisett, J. D. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.593 · Cited by 252
Histological and immunofluorescent studies on the evolution of the human atheromatous plaque
Walton, K. W., & Williamson, N. (1968) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(68)80020-1 · Cited by 237
Small, D. M., Bond, M. G., Waugh, D., Prack, M., & Sawyer, J. K. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111366 · Cited by 190
Nikkilä, E., Viikinkoski, P., Valle, M., & Frick, M. H. (1984) · BMJ · doi:10.1136/bmj.289.6439.220 · Cited by 134
Guyton, J. R., & Klemp, K. F. (1989) · Europe PMC (PubMed Central) · Cited by 117
A study of atherosclerosis regression in Macaca mulatta
Wagner, W. D., Clair, R. W. S., & Clarkson, T. B. (1980) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(80)90052-0 · Cited by 111
Quantitative computer techniques for analyzing coronary arteriograms
Brown, B. G., Bolson, E. L., & Dodge, H. T. (1986) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(86)90024-1 · Cited by 106
Self-citationMass transport, atherogenesis, and risk.
Fry, D. L. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.1.88 · Cited by 99
Guyton, J. R., Bocan, T. M. A., & Schifani, T. A. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.6.644 · Cited by 74
Characteristics of the plaque under a coronary thrombus
Tracy, R. E., Devaney, K. O., & Kissling, G. E. (1985) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00737168 · Cited by 71
Can atherosclerotic plaques regress? Anatomic and biochemical evidence from nonhuman animal models
Wissler, R. W., & Vesselinovitch, D. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91253-3 · Cited by 59
Bocan, T. M. A., & Guyton, J. R. (1985) · PubMed · Cited by 54
Nash, D. T., Gensini, G. G., & Esente, P. (1982) · International Journal of Cardiology · doi:10.1016/0167-5273(82)90008-0 · Cited by 53
Ekelund, L. G., Suchindran, C., Karon, J. M., McMahon, R. P., & Tyroler, H. A. (1990) · Circulation · doi:10.1161/01.cir.81.5.1568 · Cited by 52
Krempler, F., Kostner, G. M., Roscher, A., Bolzano, K., & Sandhofer, F. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37824-x · Cited by 47
Plaque Hemorrhages, Their Genesis and Their Role in Supra-Plaque Thrombosis and Atherogenesis
Constantinides, P. (1990) · Springer eBooks · doi:10.1007/978-1-4612-3326-8_26 · Cited by 42
Atherosclerosis: inhibition of regression as therapeutic possibilities.
Davies, M. J., KRIKLER, D. M., & Katz, D. R. (1991) · Heart · doi:10.1136/hrt.65.6.302 · Cited by 40
Coronary vasomotor tone during static and dynamic exercise
Hess, O. M., Bortone, A. S., Eid, K., Gage, J. E., Nonogi, H., Grimm, J., & Krayenbuehl, H. P. (1989) · European Heart Journal · doi:10.1093/eurheartj/10.suppl_f.105 · Cited by 30
Cited by
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,533
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
Suwaidi, J. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R., & Lerman, A. (2000) · Circulation · doi:10.1161/01.cir.101.9.948 · Cited by 2,043
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028
Metadata
- Authors
- Brown, B. G., Zhao, X. Q., Sacco, D. E., & Albers, J. J.
- Venue
- Circulation
- Published
- 1993-06
- Volume
- 87
- Issue
- 6
- Pages
- 1781-1791
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2089900480
- Cited by
- 821
- References
- 57
- FWCI
- 60.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.